HBOX Therapies is a company that has developed a technology that facilitates lung-protective treatment of respiratory patients, the patented platform technology HBOX (Hyperbaric Blood Oxygenation). The management team of HBOX Therapies consists of the founders and shareholders Dr. Peter Schlanstein, Dr. Matthias Menne and Niklas Steuer.
Location: Germany, North Rhine-Westphalia, Aachen
Employees: 1-10
Total raised: $2.45M
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.03.2023 | Seed | $2.45M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 02.03.2023 | MedTech startup HBOX Therapies receives €2.3m in seed fundin... | February 22, 2023 | htgf.de/en... |
| 23.02.2023 | HBOX Therapies Raises €2.3M in Seed Funding | Hbox Therapies, an Aachen, Germany-based MedTech startup that develops innovative treatment method f... | finsmes.co... |
| 22.02.2023 | RTWH Aachen spinoff HBOX scoops €2.3 million to address new ... | Aachen researchers have devised a minimally-invasive medical kit said to exchange oxygen with carbon... | tech.eu/20... |
| - | hbox | “HBOX Therapies GmbH – Eine andere WordPress-Site.” | fastfounde... |